This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Antitrust laws not over-the-counter cold remedy for patent fights, US DOJ’s Kallay says

By Khushita Vasant ( October 11, 2025, 01:38 GMT | Insight) -- Companies looking to bring a successful antitrust claim under the rule of reason, including patent disputes, must allege harm to the competitive process — because antitrust laws aren’t an “over-the-counter cold remedy” for contract or tort disputes, according to a the top antitrust enforcer at the US Department of Justice.Companies looking to bring a successful antitrust claim under the rule of reason — including patent disputes — must allege harm to the competitive process, because antitrust laws aren’t an “over-the-counter cold remedy” for contract or tort disputes, one of the top antitrust enforcers at the US Department of Justice said Friday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login